Watchdog group warns of serious side effects in Chantix

05/21/2008 | NYTimes.com · Wall Street Journal, The

Chantix, Pfizer's smoking-cessation drug, has been associated with more than 1,000 serious incidents and problems including diabetes, seizures and heart trouble, according to a report by the Institute for Safe Medication Practices based on an analysis of adverse events filed with the FDA. Pfizer said the existing label for Chantix is consistent with its safety profile.

View Full Article in:

NYTimes.com · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA